Australian study trials turmeric for Alzheimer’s

Sydney researchers are using brain amyloid imaging to test the effects of curcumin – the active ingredient of the spice turmeric – to prevent or delay the Alzheimer’s disease.

A joint project of the McCusker Alzheimer’s Research Foundation and Anglican Retirement Villages, the KARVIAH study will randomise 100 people to either curcumin or placebo, with brain imaging at baseline then at 12 months to quantify amyloid buildup and structural changes.

Unlike earlier drug trials for Alzheimer